Wiley, one of the world’s largest publishers and a global leader in research and learning, has announced the highly anticipated 2024 release of its Wiley Identifier of Natural Products (AntiBase Library + ChemWindow). This latest unveiling marks a significant leap forward in the realm of drug discovery and research, poised to empower scientists and researchers worldwide.
Boasting an expansive repertoire of over 95,000 compounds, this burgeoning natural products database emerges as a potent screening tool for drug discovery, facilitating the identification of potential novel compounds with antimicrobial, antitumor, and other coveted therapeutic effects. Beyond pharmaceuticals, its utility transcends into various sectors including food and cosmetics, agriculture, pesticides, and beyond, where the utilization of natural products is prevalent.
In a move set to catalyze innovation, the 2024 release introduces an impressive array of 37,000 new compounds into the repository, bolstering its already formidable arsenal. These additions are complemented by spectra computed utilizing Wiley's proprietary artificial intelligence (AI) technologies, enhancing the database’s efficacy and relevance in contemporary research endeavors.
Central to the Wiley Identifier of Natural Products is its integration of the ChemWindow software, renowned for its sophisticated high-performance data mining and chemical databasing capabilities. By seamlessly amalgamating the comprehensive AntiBase library with ChemWindow’s cutting-edge tools, researchers are empowered to expedite their investigations, leveraging both external commercial libraries and internal knowledge repositories with unparalleled efficiency.
The implications of this groundbreaking release are profound, promising to revolutionize the landscape of drug discovery and research. By harnessing the collective power of advanced technologies and vast data repositories, Wiley continues to spearhead efforts aimed at advancing scientific knowledge and catalyzing innovation on a global scale.
Click here to read the original press release.
